Skip to main content
. 2023 Jul 15;15(7):4962–4969.

Table 5.

Comparison of adverse reactions between the two groups

Groups Weakness/cramps (n) Edema (n) Muscle tenderness in both legs (n) Total incidence
Control group (n=24) 2 (8.3) 2 (8.3) 2 (8.3) 6 (24.9)
Observation group (n=24) 1 (4.2) 0 (0) 0 (0) 1 (4.2)
χ2 4.1811
P 0.0409